2,281 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by LVW Advisors LLC

LVW Advisors LLC acquired a new position in shares of Natera, Inc. (NASDAQ:NTRA) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,281 shares of the medical research company’s stock, valued at approximately $209,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Fifth Third Bancorp increased its position in Natera by 3.0% during the 4th quarter. Fifth Third Bancorp now owns 6,216 shares of the medical research company’s stock worth $389,000 after purchasing an additional 179 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in Natera by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 45,469 shares of the medical research company’s stock valued at $2,012,000 after buying an additional 230 shares during the period. Oliver Lagore Vanvalin Investment Group grew its holdings in Natera by 109.3% in the 4th quarter. Oliver Lagore Vanvalin Investment Group now owns 745 shares of the medical research company’s stock valued at $47,000 after buying an additional 389 shares during the period. RiverPark Advisors LLC purchased a new stake in Natera in the 4th quarter valued at about $27,000. Finally, Banque Cantonale Vaudoise grew its holdings in Natera by 6.6% in the 1st quarter. Banque Cantonale Vaudoise now owns 7,235 shares of the medical research company’s stock valued at $662,000 after buying an additional 451 shares during the period. Hedge funds and other institutional investors own 99.90% of the company’s stock.

Wall Street Analyst Weigh In

NTRA has been the topic of a number of recent analyst reports. BTIG Research upped their target price on Natera from $100.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, May 13th. TD Cowen lifted their price objective on shares of Natera from $123.00 to $137.00 and gave the stock a “buy” rating in a report on Friday, May 10th. Piper Sandler lifted their price objective on shares of Natera from $110.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, May 14th. The Goldman Sachs Group lifted their price objective on shares of Natera from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 15th. Finally, StockNews.com raised shares of Natera from a “sell” rating to a “hold” rating in a report on Friday, May 17th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $101.19.

Insiders Place Their Bets

In other Natera news, insider Solomon Moshkevich sold 80,000 shares of Natera stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $90.82, for a total transaction of $7,265,600.00. Following the transaction, the insider now owns 117,560 shares of the company’s stock, valued at approximately $10,676,799.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Natera news, CFO Michael Burkes Brophy sold 1,378 shares of Natera stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $92.62, for a total transaction of $127,630.36. Following the transaction, the chief financial officer now owns 70,646 shares of the company’s stock, valued at approximately $6,543,232.52. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Solomon Moshkevich sold 80,000 shares of Natera stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $90.82, for a total value of $7,265,600.00. Following the transaction, the insider now directly owns 117,560 shares in the company, valued at approximately $10,676,799.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 184,665 shares of company stock worth $17,732,033. Company insiders own 7.60% of the company’s stock.

Natera Price Performance

Shares of Natera stock opened at $108.29 on Monday. The company has a current ratio of 4.12, a quick ratio of 3.98 and a debt-to-equity ratio of 0.36. The company’s 50-day moving average price is $104.52 and its two-hundred day moving average price is $86.00. Natera, Inc. has a 52 week low of $36.90 and a 52 week high of $117.23.

Natera (NASDAQ:NTRA) last posted its quarterly earnings data on Thursday, May 9th. The medical research company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.72) by $0.16. The firm had revenue of $367.70 million for the quarter, compared to the consensus estimate of $316.31 million. Natera had a negative return on equity of 49.72% and a negative net margin of 30.24%. The business’s revenue for the quarter was up 52.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($1.23) EPS. Equities research analysts expect that Natera, Inc. will post -2.43 EPS for the current fiscal year.

About Natera

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.